๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

โœ Scribed by Christos Kosmas; Nicolas B. Tsavaris; Aristidis Polyzos; Haralambos P. Kalofonos; Evangelos Sepsas; Nikolaos A. Malamos; Maria Vadiaka; Theodosios Dosios; Minas J. Antonopoulos

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
101 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gemcitabine and vinorelbine in advanced
Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma : A Phase II study
โœ Rogerio Lilenbaum; Roberto Cano; Michael Schwartz; Leonard Siegel; Jose Lutzky; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

The authors conducted a Phase II study to evaluate the activity of the combination of gemcitabine and vinorelbine in patients with advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS. Patients were eligible if they had Stage IIIB (malignant pleural effusion) or Stage IV NSCLC, no prior chemo

UFT plus cisplatin combination chemother
UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma : A multiinstitutional Phase II trial
โœ Yukito Ichinose; Kozo Yosimori; Shuichi Yoneda; Mutsuo Kuba; Shoji Kudoh; Hisano ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 2 views

## Background: Combination chemotherapy comprised of oral uft (a combination of tegafur and uracil) and cisplatin was shown to be an effective regimen for the treatment of advanced nonsmall cell lung carcinoma and to be associated with a low incidence rate of toxicity in a previous, single institut